These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6405418)

  • 1. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life.
    Heffner TG; Seiden LS
    Psychopharmacology (Berl); 1983; 79(2-3):115-9. PubMed ID: 6405418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
    Erinoff L; MacPhail RC; Heller A; Seiden LS
    Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-induced behavioral disruption in rats chronically depleted of brain dopamine.
    Kallman MJ; Spencer RM; White AT; Chance WT; Rosecrans JA
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):115-25. PubMed ID: 571130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.
    Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P
    Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired acquisition and operant responding after neonatal dopamine depletion in rats.
    Moy SS
    Pharmacol Biochem Behav; 1995 Oct; 52(2):433-41. PubMed ID: 8577812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
    Olds ME; Yuwiler A
    Psychopharmacology (Berl); 1985; 87(4):484-9. PubMed ID: 3936107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB; Iuvone PM; Holtzman SG
    Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model.
    Van Keuren KR; Stodgell CJ; Schroeder SR; Tessel RE
    Brain Res; 1998 Jan; 780(1):56-66. PubMed ID: 9473587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lever pressing responses under a fixed-ratio schedule of mice with 6-hydroxydopamine-induced dopamine depletion in the nucleus accumbens.
    Tsutsui Y; Nishizawa K; Kai N; Kobayashi K
    Behav Brain Res; 2011 Feb; 217(1):60-6. PubMed ID: 20943202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal brain dopamine depletion and the cortical and behavioral consequences of enriched postweaning environment.
    Pappas BA; Murtha SJ; Park GA; Condon KT; Szirtes RM; Laventure SI; Ally A
    Pharmacol Biochem Behav; 1992 Aug; 42(4):741-8. PubMed ID: 1513856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of accumbens dopamine in lever pressing and response allocation: effects of 6-OHDA injected into core and dorsomedial shell.
    Sokolowski JD; Salamone JD
    Pharmacol Biochem Behav; 1998 Mar; 59(3):557-66. PubMed ID: 9512057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
    Fobes JL; Olds ME
    Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of selective dopamine, norepinephrine or catecholamine depletion on activity and learning in the developing rat.
    Raskin LA; Shaywitz BA; Anderson GM; Cohen DJ; Teicher MH; Linakis J
    Pharmacol Biochem Behav; 1983 Nov; 19(5):743-9. PubMed ID: 6647508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of central dopamine depletion on the d-amphetamine discriminative stimulus in rats.
    Woolverton WL; Cervo L
    Psychopharmacology (Berl); 1986; 88(2):196-200. PubMed ID: 3006111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.